Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression post-transcriptionally.
• Global down-regulation of miRNAs observed in prostate cancer (PCa) cell lines and tumors.
• Demethylating agent treatment increased miRNA expression in PCa cells.

Purpose of the Study:

• To investigate the role of specific miRNAs in prostate cancer pathogenesis.
• To identify and validate candidate miRNAs involved in PCa development.
• To explore the potential of miRNAs as biomarkers for PCa detection.

Main Methods:

• Screening of miRNAs in PCa cell lines and patient samples.
• Analysis of miRNA expression levels and promoter methylation.
• Validation of candidate miRNA targets using gene expression profiling.
• Functional studies involving miRNA over-expression and gene silencing.

Main Results:

• miR-130a was found to be significantly down-regulated in PCa.
• Down-regulation of miR-130a correlated with promoter hypermethylation and repressive histone marks.
• Methylation levels of miR-130a effectively distinguished PCa from non-malignant tissues (AUC=0.956).
• Urine samples showed high specificity for non-invasive PCa detection (AUC=0.89).
• Over-expression of miR-130a suppressed PCa cell viability and invasion, and increased apoptosis.
• DEPD1C and SEC23B were validated as targets of miR-130a.

Conclusions:

• miR-130a functions as a tumor suppressor miRNA in prostate cancer.
• Epigenetic regulation, specifically promoter hypermethylation, contributes to miR-130a down-regulation in PCa.
• miR-130a plays a role in regulating key molecular and phenotypic features of prostate carcinogenesis.
• miR-130a holds promise as a biomarker for non-invasive PCa detection.